Yahoo Web Search

Search results

  1. 3 days ago · Apart from Ms Thapar, other selling shareholders in the Offer for Sale (OFS) include promoters Satish Ramanlal Mehta, Sunil Rajanikant Mehta and Samit Satish Mehta. Promoted Listen to the latest ...

  2. 4 days ago · Emcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita Thapar, a Shark Tank India investor. Thapar to sell around 12.68 lakh shares through the offer for ...

  3. 1 day ago · Under the OFS, investors who cut their stakes included promoters Namita Thapar, Satish Ramanlal Mehta, Sunil Rajanikant Mehta, and Samit Satish Mehta, as well as BC Investments IV Ltd, an affiliate of the US-based private equity major Bain Capital. Shark Tank fame Namita Thapar will likely make around ₹ 127 crore through the IPO.

  4. 3 days ago · 3 Min Read. The initial share sale of Pune-based Emcure Pharmaceuticals will open for public subscription on Wednesday, July 3. The three-day bidding process will conclude on July 5. NSE. Ahead of the issue opening, shares of the company are commanding a premium of ₹290 in the unlisted market.

  5. 3 days ago · Emcure Pharmaceuticals IPO Issue timeline. Bid Start 03-Jul-2024. Bid End 05-Jul-2024. Allotment 08-Jul-2024. Refund Initiation 09-Jul-2024. Demat Allocation 09-Jul-2024. Listing 10-Jul-2024. Strengths & Risks. 30 second IPO.

  6. 3 days ago · The selling shareholders in the OFS include promoters Satish Ramanlal Mehta, Sunil Rajanikant Mehta, Namita Vikas Thapar, and Samit Satish Mehta.

  7. 4 days ago · Emcure intends to raise Rs 1,952.03 crore via an initial public offering which is a mix of fresh issuance of shares worth Rs 800 crore, and an offer-for-sale (OFS) of 1.14 crore shares worth Rs ...